BactiQuant AS (OCSE:BACTIQ) Piotroski F-Score: 5 (As of Jun. 26, 2026) — 25% Above Median


OCSE:BACTIQ BactiQuant AS OCSE:BACTIQ
57 GF Score
Price kr2.52
GF Value kr2.37
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is BactiQuant AS Piotroski F-Score?

BactiQuant AS OCSE:BACTIQ +1.61% 57 Piotroski F-Score is 5 as of Jun. 26, 2026, which is 25% above its 10-year median of 4.00. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 57/100 and a GF Value™ of kr2.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 2,979 Industrial Products companies, BactiQuant AS ranks better than 56.63% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

BactiQuant AS has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for BactiQuant AS's Piotroski F-Score or its related term are showing as below:

OCSE:BACTIQ' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 5
Current: 5

During the past 8 years, the highest Piotroski F-Score of BactiQuant AS was 5. The lowest was 2. And the median was 4.

BactiQuant AS  (OCSE:BACTIQ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


BactiQuant AS Piotroski F-Score Related Terms


BactiQuant AS Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for BactiQuant AS's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS Piotroski F-Score Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 4.00 3.00 5.00 2.00 5.00

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 2.00 0.00 5.00

OCSE:BACTIQ vs VLTO, ZWS, CECO: Piotroski F-Score Comparison

For the Pollution & Treatment Controls subindustry, BactiQuant AS's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BactiQuant AS Piotroski F-Score vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, BactiQuant AS's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where BactiQuant AS's Piotroski F-Score falls into.


OCSE:BACTIQ
57GF Score
BactiQuant AS OCSE:BACTIQ
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was kr-13.83 Mil.
Cash Flow from Operations was kr-10.51 Mil.
Revenue was kr8.32 Mil.
Gross Profit was kr-2.19 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (14.695 + 28.068) / 2 = kr21.3815 Mil.
Total Assets at the begining of this year (Dec24) was kr14.70 Mil.
Long-Term Debt & Capital Lease Obligation was kr6.90 Mil.
Total Current Assets was kr23.54 Mil.
Total Current Liabilities was kr3.91 Mil.
Net Income was kr-13.72 Mil.

Revenue was kr7.18 Mil.
Gross Profit was kr-3.36 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (25.503 + 14.695) / 2 = kr20.099 Mil.
Total Assets at the begining of last year (Dec23) was kr25.50 Mil.
Long-Term Debt & Capital Lease Obligation was kr8.49 Mil.
Total Current Assets was kr8.60 Mil.
Total Current Liabilities was kr5.52 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

BactiQuant AS's current Net Income (TTM) was -13.83. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

BactiQuant AS's current Cash Flow from Operations (TTM) was -10.51. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=-13.833/14.695
=-0.94134059

ROA (Last Year)=Net Income/Total Assets (Dec23)
=-13.723/25.503
=-0.53809356

BactiQuant AS's return on assets of this year was -0.94134059. BactiQuant AS's return on assets of last year was -0.53809356. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

BactiQuant AS's current Net Income (TTM) was -13.83. BactiQuant AS's current Cash Flow from Operations (TTM) was -10.51. ==> -10.51 > -13.83 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=6.896/21.3815
=0.32252181

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=8.486/20.099
=0.42221006

BactiQuant AS's gearing of this year was 0.32252181. BactiQuant AS's gearing of last year was 0.42221006. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=23.541/3.911
=6.01917668

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=8.601/5.52
=1.55815217

BactiQuant AS's current ratio of this year was 6.01917668. BactiQuant AS's current ratio of last year was 1.55815217. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

BactiQuant AS's number of shares in issue this year was 29.774. BactiQuant AS's number of shares in issue last year was 26.325. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-2.193/8.319
=-0.26361342

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-3.357/7.175
=-0.46787456

BactiQuant AS's gross margin of this year was -0.26361342. BactiQuant AS's gross margin of last year was -0.46787456. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=8.319/14.695
=0.56611092

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=7.175/25.503
=0.28133945

BactiQuant AS's asset turnover of this year was 0.56611092. BactiQuant AS's asset turnover of last year was 0.28133945. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+1+0+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

BactiQuant AS has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
BactiQuant AS (OCSE:BACTIQ) has a Piotroski F-Score of 5 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on BactiQuant AS and its competitors. This is 25% above median its historical median of 4.00. Over the past decade, BactiQuant AS's Piotroski F-Score has ranged from 2.00 to 5.00. According to the industry distribution chart, BactiQuant AS ranks #1292 out of 2979 companies in the Industrial Products industry, placing it in the top 43.4%.
Is BactiQuant AS's Piotroski F-Score too high?
BactiQuant AS's current Piotroski F-Score of 5 is 25% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 5.00. The Industrial Products industry median Piotroski F-Score is 5.00. BactiQuant AS's value of 5 is 0% at this industry median. Based on the distribution chart, BactiQuant AS ranks #1292 out of 2979 companies in the Industrial Products industry, which is above the industry midpoint. Overall, BactiQuant AS has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Piotroski F-Score compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #1292 out of 2979 companies for Piotroski F-Score. This puts BactiQuant AS in the upper half of its industry. The industry median Piotroski F-Score is 5.00. BactiQuant AS's value of 5 is 0% at this benchmark. Historically, BactiQuant AS's own Piotroski F-Score has ranged from 2.00 to 5.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, BactiQuant AS has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for an Industrial Products company?
The median Piotroski F-Score among Industrial Products companies is 5.00, based on 2,979 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BactiQuant AS's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current Piotroski F-Score is 5, which is 25% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.37, compared to a current price of kr2.52 — trading 6.3% above its estimated fair value. The current Piotroski F-Score is 5, which is 25% above median its 10-year median of 4.00 and 0% at the Industrial Products industry median of 5.00. BactiQuant AS's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current Piotroski F-Score is 5 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?

Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued. The current stock price of kr2.52 is trading 6.3% above its estimated GF Value™ of kr2.37. GuruFocus considers BactiQuant AS to be Fairly Valued.

Key valuation signals for OCSE:BACTIQ:

  • Piotroski F-Score: 5 (25% above median its 10-year median of 4.00)
  • GF Value™: kr2.37 vs. price of kr2.52 (6.3% above fair value)
  • GF Score™: 57/100 with 4 warning signs
  • Industry Position: 0% at the Industrial Products median (#1292 of 2979)

No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BactiQuant AS Business Description

Address Blokken 75, Birkeroed, DNK, DK-3460
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
57GF Score

Get the complete analysis for OCSE:BACTIQ

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.52
Price
kr2.37
GF Value